Clinical Excellence
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Clinical Excellence
-
DaVita Celebrates Donors During National Donate Life Month
Nearly 100,000 people in the U.S. need a kidney transplant,[1] but limited availability of organs for people on the wait list can result in long wait times. For some transplant candidates, living…
-
DaVita Celebrates Its Teammates in 2022 Villagewide Conference
DaVita’s internal conference, Villagewide, returned March 29–30, 2022. This event highlights and celebrates teammates (employees) and provides updates and accomplishments around the…
-
Dietitians Play a Key Role in Transplant Success—And for One DaVita Teammate, It’s Personal
For DaVita teammate and Registered Dietitian (RD) Cristal Chora, helping patients process powerful emotions is all in a day’s work. “People are scared, they’re angry. Above all they’re overwhelmed. Entering into dialysis is a huge life disruption.” Chora knows this reality better than anyone. While still in her teens, she was diagnosed with end stage […]
-
Using Predictive Analytics to Move Kidney Care Upstream
Of the 37 million Americans who have kidney disease, an estimated 90% don’t know they have it. Often, it can go undetected because patients can present few or no symptoms until they approach or…
-
All Three COVID-19 Vaccines Shown Effective for People with ESKD
While clinical studies have helped demonstrate the effectiveness and immunogenicity of the COVID-19 vaccines approved or authorized in the U.S. (Pfizer, Moderna and Johnson & Johnson), these…
